[
  {
    "ts": null,
    "headline": "Regeneron’s R&D approach scores dual wins against Alexion’s Ultomiris and in lymphoma",
    "summary": "At this year’s ASH conference, Regeneron posted results for treatments that could disrupt the standards of care in two blood-related diseases.",
    "url": "https://finnhub.io/api/news?id=1dcdd0dabd455f74e50b8aa240fa7ca65208408919edfd695049c93ec4d4bb3a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733988417,
      "headline": "Regeneron’s R&D approach scores dual wins against Alexion’s Ultomiris and in lymphoma",
      "id": 131941426,
      "image": "https://imgproxy.divecdn.com/24hfIsbWEv_BeWmT82kahR0LURqNCSychw8LpcWvhyM/g:ce/rs:fit:770:435/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9TY3JlZW5zaG90XzIwMjQtMTItMTFfMTM1MTExLnBuZw==.webp",
      "related": "REGN",
      "source": "Yahoo",
      "summary": "At this year’s ASH conference, Regeneron posted results for treatments that could disrupt the standards of care in two blood-related diseases.",
      "url": "https://finnhub.io/api/news?id=1dcdd0dabd455f74e50b8aa240fa7ca65208408919edfd695049c93ec4d4bb3a"
    }
  }
]